Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FY1U6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,911
Award facts
- Contract value 100% obligated
- $14,910.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a contract ceiling value of $14,910.92. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and the order is scheduled for completion by November 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle that runs through December 2026 and authorizes the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal contracting experience with the Defense Logistics Agency and serves critical medical procurement needs for military and veteran healthcare systems. The company's portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a child contract under the larger DLA Troop Support Medical IDC, this delivery order exemplifies the company's ongoing role as a key supplier within the federal medical supply chain and reflects the Defense Logistics Agency's reliance on established prime vendor relationships to ensure consistent pharmaceutical availability across military healthcare programs.
Quick answers
Who was awarded contract SPE2DB26FY1U6?
SPE2DB26FY1U6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FY1U6 worth?
The government has obligated $14,911 on SPE2DB26FY1U6.
Is contract SPE2DB26FY1U6 an order under another contract?
Yes. SPE2DB26FY1U6 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1U6 competed?
The extent of competition for SPE2DB26FY1U6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award